Sage Therapeutics Income Statement

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2014	FY 2013
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Interest and Dividend Income	635.51	1,565	605.58	3,029	4,022
Total Interest Expense	5,544	2,221	1,395	-	-
Net Interest Income	-4,908	-655.69	-789.53	3,029	4,022
Brokerage Commission	15,664	17,130	15,740	15,480	7,911
Gain on Sale of Investments (Rev)	25,182	19,552	24,723	-	-
Other Revenue	40,908	36,504	39,454	17,339	14,652
Revenue	76,846	72,531	79,128	35,848	26,585
Revenue Growth (YoY)	-2.11%	-8.34%	120.73%	34.84%	-
Cost of Services Provided	52,948	50,997	49,036	23,815	25,052
Total Operating Expenses	52,948	50,997	49,036	23,815	25,052
Operating Income	23,898	21,534	30,092	12,033	1,533
Other Non-Operating Income (Expenses)	247.05	9.22	18.24	-4.97	42.68
EBT Excluding Unusual Items	24,145	21,543	30,110	12,028	1,576
Gain (Loss) on Sale of Investments	-0.02	-0.02	3,035	-	-
Pretax Income	24,145	21,543	33,145	12,028	1,576
Income Tax Expense	4,943	4,425	6,131	2,610	422.71
Net Income	19,202	17,118	27,014	9,418	1,153
Net Income to Common	19,202	17,118	27,014	9,418	1,153
Net Income Growth	-11.29%	-36.63%	186.83%	716.61%	-
Shares Outstanding (Basic)	87	69	69	16	16
Shares Outstanding (Diluted)	123	105	105	16	16
Shares Change (YoY)	16.95%	-	551.73%	0.51%	-
EPS (Basic)	220.37	246.84	389.53	585.00	72.00
EPS (Diluted)	156.48	163.15	257.46	585.00	72.00
EPS Growth	-24.15%	-36.63%	-55.99%	712.50%	-
Free Cash Flow	-576,674	-163,329	40,960	-11,983	-24,415
Free Cash Flow Per Share	-4699.50	-1556.63	390.38	-744.32	-1524.16
Dividend Per Share	48.900	48.900	-	-	-
Operating Margin	31.10%	29.69%	38.03%	33.57%	5.77%
Profit Margin	24.99%	23.60%	34.14%	26.27%	4.34%
Free Cash Flow Margin	-750.43%	-225.19%	51.77%	-33.43%	-91.83%
Effective Tax Rate	20.47%	20.54%	18.50%	21.70%	26.82%
Revenue as Reported	82,390	74,752	80,523	35,848	26,585

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.